Holen Sie sich die Stockscreener-App
5.61
12.20%
0.61
Sage Therapeutics Inc Aktie (SAGE) Neueste Nachrichten
Postpartum Depression Therapeutics Market Size in the 7MM was ~USD 260 Million in 2023, is expected to grow by 2034, and estimates DelveInsight - The Globe and Mail
SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit - The Eastern Progress Online
SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Eastern Progress Online
Sage Therapeutics Inc Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsSAGE - The Eastern Progress Online
Brokerages Set Sage Therapeutics, Inc. (NASDAQ:SAGE) Price Target at $11.53 - MarketBeat
Sage Therapeutics price target lowered to $6 from $10 at Stifel - Yahoo Finance
Where Sage Therapeutics Stands With Analysts - Benzinga
Stifel Nicolaus Has Lowered Expectations for Sage Therapeutics (NASDAQ:SAGE) Stock Price - MarketBeat
Sage Therapeutics' SWOT analysis: navigating challenges in CNS drug stock - Investing.com
Sage Therapeutics' SWOT analysis: navigating challenges in CNS drug stock By Investing.com - Investing.com UK
SAGE SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - The Eastern Progress Online
Levi & Korsinsky Notifies Sage Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineSAGE - The Eastern Progress Online
Layoff Tracker: Bavarian, BenevolentAI, Chroma Medicine and Nvelop Therapeutics Cut Staff - BioSpace
Sage Therapeutics shares stay Neutral rated by Mizuho, target cut on discontinued pipeline - Investing.com UK
Sage Therapeutics, Inc. (NASDAQ:SAGE) Shares Sold by Fmr LLC - MarketBeat
Shareholders that lost money on Sage Therapeutics, Inc.(SAGE) should contact The Gross Law Firm about pending Class ActionSAGE - The Eastern Progress Online
Investors who lost money on Sage Therapeutics, Inc.(SAGE) should contact The Gross Law Firm about pending Class ActionSAGE - The Eastern Progress Online
Class Action Filed Against Sage Therapeutics, Inc. (SAGE) Seeking Recovery for InvestorsContact The Gross Law Firm - The Eastern Progress Online
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sage Therapeutics, Inc.(SAGE) Shareholders - The Eastern Progress Online
Sage Therapeutics, Inc. (NASDAQ:SAGE) Shares Sold by Jacobs Levy Equity Management Inc. - MarketBeat
RTW Investments LP Buys 111,123 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) - MarketBeat
RBC Capital Upgrades Sage Therapeutics (SAGE) - MSN
Deutsche Bank Initiates Coverage of Sage Therapeutics (SAGE) with Hold Recommendation - MSN
Sage Therapeutics, Inc. Announces Retirement of Jeffrey M. Jonas as Member of Board of Directors , Effective December 1, 2024 - Marketscreener.com
Sage Therapeutics, Inc. Announces Resignation of Jeffrey M. Jonas as Member of Board of Directors , Effective December 1, 2024 - Marketscreener.com
SAGE (Sage Therapeutics) Change In Inventory : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
SAGE (Sage Therapeutics) Cash Flow from Financing : $10.4 Mil (TTM As of Sep. 2024) - GuruFocus.com
Rx Rundown: Novartis, Sage Therapeutics, Eli Lilly and more - MM+M Online
Sage Therapeutics announces board member retirement By Investing.com - Investing.com Nigeria
Sage Therapeutics announces board member retirement - Investing.com India
Sage Therapeutics' SWOT analysis: stock faces hurdles amid CNS pipeline setbacks By Investing.com - Investing.com South Africa
Sage Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference - BioSpace
Sage Therapeutics' SWOT analysis: stock faces hurdles amid CNS pipeline setbacks - Investing.com
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):